Previous studies have shown that individuals with reduced DKK3 levels have a higher risk of developing breast cancer [20], ovarian cancer [21], malignant glioma [22], and pancreatic cancer [13]. This evidence concerns the gene DKK3 and pancreatic neoplasm.